z-logo
open-access-imgOpen Access
Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancer
Author(s) -
YinJu Chen,
ChiaChun Kuo,
LaiLei Ting,
LongSheng Lu,
YaChing Lu,
AnnJoy Cheng,
YunTien Lin,
ChienHo Chen,
JoTing Tsai,
JengFong Chiou
Publication year - 2017
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2017.7486
Subject(s) - homeobox protein nanog , biology , oncogene , cancer research , cancer stem cell , cancer , epithelial–mesenchymal transition , cancer cell , cell cycle , cell growth , stem cell , microbiology and biotechnology , metastasis , embryonic stem cell , induced pluripotent stem cell , genetics , gene
Piperlongumine (PL), a natural product of Piper longum , inhibits multiple malignant phenotypes. Therefore, the present study examined whether PL suppresses cancer stemness in oral cancer. The cellular effects of PL were determined by examining alterations in tumor sphere formation, cell migration, invasion, proliferation ability, chemosensitivity and radiosensitivity. Reverse transcription-quantitative polymerase chain reaction analysis and western blotting were performed in order to determine molecular expression levels. The present study revealed that PL inhibited cancer stem cell-forming ability and suppressed the expression of the stemness-related transcription factors SRY-Box 2, POU class 5 homeobox 1, and Nanog homeobox. However, it increased the expression of the differentiation marker cytokeratin 18. PL also suppressed cell migration and invasion, resulting in the elimination of the epithelial-mesenchymal transition. Furthermore, PL increased chemo- and radiosensitivity and suppressed tumor growth in vitro and in vivo . The results of the present study suggested that PL inhibits malignant phenotypes via the suppression of cancer stemness in oral cancer. Thus, PL may serve as an effective therapeutic agent for oral cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom